Literature DB >> 7184469

Experimental acantholysis by complement-fixing intercellular antibodies.

T Hashimoto, M Sugiura, S Kurihara, T Nishikawa, H Hatano.   

Abstract

Complement-fixing intercellular antibodies were detected in 10 of 17 sera from untreated pemphigus patients. The role of complement in the organ culture system was investigated using these sera. Ten sera possessing complement-fixing intercellular antibodies showed IgG binding to the intercellular substance in the organ-cultured skin and acantholysis-like changes were observed in eight cases. C3 deposition was not seen in any case. However, after treatment of the sections of cultured skin with fresh normal human serum, complement fixation of the intercellular substance by bound IgG was revealed in all the ten cases. No significant differences in the grade of acantholysis-like changes between the complement-depleted system and the complement-supplied system were observed. Complement does not appear to be necessary in the acantholytic process in the in vitro organ culture system, even though we considered the presence of complement-fixing intercellular antibodies.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7184469     DOI: 10.1007/bf00509037

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  24 in total

1.  [Studies of the complement fixing antibodies in bullous pemphigoid and pemphigus (author's transl)].

Authors:  S Kurihara
Journal:  Nihon Hifuka Gakkai Zasshi       Date:  1978-06

2.  Capability of complement fixation by in vivo bound antibodies in pemphigus skin lesions.

Authors:  T Nishikawa; S Kurihara; T Harada; M Sugawara; H Hatano
Journal:  Clin Exp Dermatol       Date:  1978-03       Impact factor: 3.470

3.  Direct immunofluorescent study of the skin on occurrence of complement in pemphigus.

Authors:  T van Joost; R H Cormane; K W Pondman
Journal:  Br J Dermatol       Date:  1972-11       Impact factor: 9.302

4.  Complement immunofluorescent staining in bullous pemphigoid.

Authors:  R E Jordon; W M Sams; E H Beutner
Journal:  J Lab Clin Med       Date:  1969-10

5.  Organ culture studies of pemphigus antibodies. II. Ultrastructural comparison between acantholytic changes in vitro and human pemphigus lesions.

Authors:  M L Barnett; E H Beutner; T P Chorzelski
Journal:  J Invest Dermatol       Date:  1977-05       Impact factor: 8.551

6.  Pemphigus antibody action on skin explants: kinetics of acantholytic changes and stability of antigens in tissue cultures of normal monkey skin explants.

Authors:  J S Deng; E H Beutner; S Shu; T P Chorzelski
Journal:  Arch Dermatol       Date:  1977-07

7.  Bullous pemphigoid, herpes gestationis and linear dermatitis herpetiformis: circulating anti-basement membrane zone antibodies; in vitro studies.

Authors:  H Pehamberger; F Gschnait; K Konrad; K Holubar
Journal:  J Invest Dermatol       Date:  1980-02       Impact factor: 8.551

8.  Pemphigus acantholysis in tissue culture: studies on photo-induction.

Authors:  F Gschnait; H Pehamberger; K Holubar
Journal:  Acta Derm Venereol       Date:  1978       Impact factor: 4.437

9.  Capability of complement fixation of pemphigus antibodies in vitro.

Authors:  V Kumar; E H Beutner; T P Chorzelski; S Jablonska
Journal:  Arch Dermatol Res       Date:  1978-11-10       Impact factor: 3.017

10.  Comparison of in vivo and in vitro capability of complement fixation by pemphigus antibodies.

Authors:  T Nishikawa; S Kurihara; H Hatano
Journal:  Dermatologica       Date:  1979
View more
  2 in total

1.  Experimental human cell and tissue models of pemphigus.

Authors:  Gerda van der Wier; Hendri H Pas; Marcel F Jonkman
Journal:  Dermatol Res Pract       Date:  2010-05-26

Review 2.  The relevance of complement in pemphigoid diseases: A critical appraisal.

Authors:  Cristian Papara; Christian M Karsten; Hideyuki Ujiie; Enno Schmidt; Leon F Schmidt-Jiménez; Adrian Baican; Patricia C Freire; Kentaro Izumi; Katja Bieber; Matthias Peipp; Admar Verschoor; Ralf J Ludwig; Jörg Köhl; Detlef Zillikens; Christoph M Hammers
Journal:  Front Immunol       Date:  2022-08-16       Impact factor: 8.786

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.